Search

Search Constraints

You searched for: Author/Creator Cho, Daniel C.

Search Results

1. Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial. (March 2021)

2. Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma. Issue 26 (10th September 2021)

3. Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma. Issue 9 (20th March 2021)

5. Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920. Issue 5 (16th November 2021)